Cargando…
MicroRNAs in pancreatic cancer diagnosis and therapy
Pancreatic cancer remains a disease with very poor prognosis (only 5-6% of patients are still alive after five years). Attempts to improve the results of treatment of pancreatic cancer focus on a better understanding of the pathogenesis, and non-invasive diagnostic methods (genetic testing from peri...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Polish Society of Experimental and Clinical Immunology
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6305615/ https://www.ncbi.nlm.nih.gov/pubmed/30588176 http://dx.doi.org/10.5114/ceji.2018.80051 |